In addition, clinically used electrotransfer of plasmid DNA was employed in our study and the study was extended to another tumor model, mammary carcinoma, which has not been tested yet by transcriptional targeting using p21 promoter. The gene discussed is CDKN1A; the disease is neoplasm.